Estimation of the Number of Injecting Drug Users Attending an Outreach Syringe-Exchange Program and Infection with Human Immunodeficiency Virus (HIV) and Hepatitis C Virus: The AjUDE-Brasil Project

Journal of Urban Health

Volumn 80, Issue 1, 2003, Pages 106-114

  Caiaffa, Waleska Teixeira ^a,b   Mingoti, Sueli Aparecida ^b   Proietti, Fernando A ^a   Carneiro Proietti, Anna Bárbara ^c   Silva, Rodrigo Carazolli ^b   Lopes, Aline Cristine Souza ^a   Doneda, Denise ^d  

^a School of Medicine   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^c Hemominas Foundation   (Brazil)

^d MINISTÉRIO DA SAÚDE   (Brazil)

Author keywords

Capture recapture; HCV; HIV; Injecting drug users; Syringe exchange program

Indexed keywords

ADULT; ARTICLE; BRAZIL; DISEASE ASSOCIATION; FEMALE; HEALTH EDUCATION; HEALTH PROGRAM; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; INTERVIEW; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEROPREVALENCE; SYRINGE; VIRUS TRANSMISSION; ADDICTION; ATTITUDE TO HEALTH; BLOODBORNE BACTERIUM; CLINICAL TRIAL; CROSS-SECTIONAL STUDY; DRUG ABUSE; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIOLOGY; HEALTH; HIGH RISK BEHAVIOR; IMMUNOLOGY; MIDDLE AGED; MULTICENTER STUDY; PREVENTIVE HEALTH SERVICE; QUESTIONNAIRE; SUBSTANCE ABUSE; UTILIZATION REVIEW; VIROLOGY;

HEPATITIS C ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

ADULT; BLOOD-BORNE PATHOGENS; BRAZIL; CROSS-SECTIONAL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEPATITIS C; HEPATITIS C ANTIBODIES; HIV ANTIBODIES; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; NEEDLE SHARING; NEEDLE-EXCHANGE PROGRAMS; QUESTIONNAIRES; RISK-TAKING; SEROEPIDEMIOLOGIC STUDIES; SUBSTANCE ABUSE, INTRAVENOUS; SUBSTANCE-RELATED DISORDERS; URBAN HEALTH;

EID: 0038651139     PISSN: 10993460     EISSN: None     Source Type: Journal    
DOI: 10.1093/jurban/jtg106     Document Type: Article

References (34)

1. Garfein RS, Vlahov D, Galai N, Doherty MC, Nelson KE. Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency virus, and human T-lymphotropic viruses. Am J Public Health. 1996;86:655-661.
2. Crofts N. Going where the epidemic is. Epidemiology and control of hepatitis C among injecting drug users. Aust Fam Physician. 2001;30:420-425.
3. Oliveira MLA, Bastos FI, Telles PR, et al. Prevalence and risk factors for HBV, HCV and HDV infections among injecting drug users from Rio de Janeiro, Brazil. Brazilian J Med Biol Res. 1999;32:1107-1114.
4. Thomas DL, Astemborski J, Rai RM, et al. Natural history of hepatitis C virus infection. JAMA. 2000;284:450-456.
5. Caiaffa WT, Bastos FI. Usuários de drogas injetáveis e infecção pelo vírus da imunodeficiência humana: epidemiologia e perspectivas de intervenção. Rev Bras Epidemiol. 1998;1:190-202.
6. Bastos FI, Strathdee SA. Evaluating effectiveness of syringe exchange programmes: current issues and future prospects. Soc Sci Med. 2000;51:1771-1782.
7. Brazil. Boletim Epidemiológico de AIDS XIV. January-March 2001; Brasilia, Brazil: Ministry of Health, Secretariat for Health Policies, National STD/AIDS Coordinating Office.
8. Teixeira P, Vitoria M, Barreira D, Dhalia C, Castilho E. Aids epidemics in Brazil: present situation, national response and future trends. Actualizaciones em AIDS. 2001;9:1-9.
9. Strathdee SA, van Ameijden E, Mesquita F, et al. Can HIV epidemics among injection drug users be prevented? AIDS. 1998;12:S71-S79.
10. Strathdee SA, Patrick DM, Currie S, et al. Needle exchange is not enough: lessons from the Vancouver Injection Drug Use Study. AIDS. 1997;11:F59.
11. Bruneau J, Lamothe F, Franco E, et al. High rates of HIV infection among injection drug users participating in needle exchange programs in Montreal: results of a cohort study. Am J Epidemiol. 1997;146:994-1002.
12. Lurie, P. Dr. Lurie replies [letter]. Am J Epidemiol. 1998;148:715.
13. Lurie P, Drucker E. An opportunity lost: HIV infections associated with lack of a national needle-exchange programme in the USA. Lancet. 1997;349:604-608.
14. Taylor A, Goldberg D, Hutchinson S, Cameron S, Fox R. High risk injecting behaviour among injectors from Glasgow: cross sectional community wide surveys 1990-1999. J Epidemiol Community Health. 2001;55:766-767.
15. Domingo-Salvany A, Hartnoll RL, Maguire A, et al. Analytical considerations in the use of capture-recapture to estimate prevalence: case studies of the estimation of opiate use in the metropolitan area of Barcelona, Spain. Am J Epidemiol. 1998;148:732-740.
16. Davies AG, Cormack RM, Richardson AM. Estimation of injecting drug users in the city of Edinburgh, Scotland, and number infected with human immunodeficiency virus. Int J Epidemiol. 1999;28:117-121.
17. Mastro TD, Kitayaporn D, Weniger BG, et al. Estimating the number of HIV-infected injection drug users in Bangkok: a capture-recapture method. Am J Public Health. 1994;84:1094-1099.
18. Frischer M, Leyland A, Cormack R, et al. Estimating the population prevalence of injection drug use and infection with human immunodeficiency virus among injection drug users in Glasgow, Scotland. Am J Epidemiol. 1993;138:170-181.
19. Hay G, McKeganey N. Estimating the prevalence of drug misuse in Dundee, Scotland: an application of capture-recapture methods. J Epidemiol Community Health. 1996;50:469-472.
20. McKeganey N, Barnard M, Leyland A, Coote I, Follet E. Female streetworking prostitution and HIV infection in Glasgow. BMJ. 1992;305(6857):801-804.
21. Otis DL, Burnham KP, White GC, Anderson DR. Statistical inference from capture data on closed animal populations. Wildlife Monogr. 1978;62:1-135.
22. Abeni DD, Brancato G, Perucci CA. Capture-recapture to estimate the size of the population with human immunodeficiency virus type 1 infection. Epidemiology. 1994;5:410-414.
23. Caiaffa WT. Projeto AjUDE-BRASIL. Avaliação Epidemiológica dos Usuários de Drogas Injetáveis dos Projetos de Redução de Danos Apoiados pela CN-DST/AIDS/Brasil. Brasília, Brazil: Ministry of Health, Secretariat for Health Policies, National STD/AIDS Coordinating Office; 2001. Available at: www.aids.gov.br/final/biblioteca/avaliacao6/ajud1.htm. Accessed December 23, 2002.
24. Silva RC. Mingoti SA. Capture-Recapture Program in Turbo Pascal. Departamento de Estatística da UFMG. Belo Horizonte; 1998.
25. Darroch J N. The multiple-recapture census I: estimation of a closed population. Biometrika. 1958;45:343-359.
26. Rexstad E, Burnham K. User's Guide for Interactive Program Capture. Fort Collins, CO: Colorado Cooperative Fish and Wildlife Research Unit, Colorado State University; 1991.
27. Proietti ABC, Proietti FA, Gonçalves VE, et al. Blood collection on filter paper: a practical approach for sample collection for studies of seroprevalence among Injecting drug users. In: Thirteenth International AIDS Conference, 2000, Durban. 2000;2:348-348.
28. Proietti FA, Caiaffa WT, Proietti ABC, et al. Seroprevalence correlates of HIV and HCV infection among injection drug users attending an outreach syringe exchange program (SEP) in five cities in Brazil. In: Thirteenth International AIDS Conference, 2000, Durban. 2000;2:6.
29. Des Jarlais DC, Paone D, Milliken J, et al. Audio-computer interviewing to measure risk behaviour for HIV among injecting drug users: a quasi-randomised trial. Lancet. 1999;15(353):1657-1661.
30. Darke S. Self-report among injecting drug users: a review. Drug Alcohol Depend. 1998;51:253-263.
31. McElrath K, Chitwood DD, Griffin DK, Comerford M. The consistency of self-reported HIV risk behavior among injection drug users. Am J Public Health. 1994;12:1965-1970.
32. Anthony JC, Vlahov D, Celentano D, et al. Self-reported interview data for a study on HIV-1 infection among intravenous drug users: description of methods and preliminary evidence on validity. J Drug Issues. 1991;21:739-757.
33. Des Jarlais DC, Dehne K, Casabona J. HIV surveillance among injecting drug users. AIDS. 2001;15(suppl 3):S13-S22.
34. Stein MD, Maksad J, Clarke J. Hepatitis C disease among injection drug users: knowledge, perceived risk and willingness to receive treatment. Drug Alcohol Depend. 2001;61:211-215.